{"id":345190,"date":"2025-08-24T17:27:36","date_gmt":"2025-08-24T17:27:36","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-pyxis-oncology\/"},"modified":"2025-08-24T17:27:36","modified_gmt":"2025-08-24T17:27:36","slug":"how-to-buy-pyxis-oncology","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334099,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-345190","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Pyxis Oncology, Inc. (PYXS) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Pyxis Oncology, Inc. (PYXS)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Pyxis Oncology, Inc. (PYXS) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Pyxis Oncology, Inc. (PYXS)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS) v\u00e0 \u0111\u01b0a ra quy\u1ebft \u0111\u1ecbnh \u0111\u1ea7u t\u01b0 th\u00f4ng minh v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ea7y h\u1ee9a h\u1eb9n n\u00e0y v\u1edbi ti\u1ec1m n\u0103ng t\u0103ng gi\u00e1 547% theo c\u00e1c nh\u00e0 ph\u00e2n t\u00edch.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS) v\u00e0 \u0111\u01b0a ra quy\u1ebft \u0111\u1ecbnh \u0111\u1ea7u t\u01b0 th\u00f4ng minh v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ea7y h\u1ee9a h\u1eb9n n\u00e0y v\u1edbi ti\u1ec1m n\u0103ng t\u0103ng gi\u00e1 547% theo c\u00e1c nh\u00e0 ph\u00e2n t\u00edch."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb ung th\u01b0 \u0111\u1ed9t ph\u00e1 ti\u1ebfp theo? Pyxis Oncology \u0111\u1ea1i di\u1ec7n cho th\u1ebf gi\u1edbi \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ea7y h\u1ee9ng kh\u1edfi, n\u01a1i th\u00e0nh c\u00f4ng trong c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng c\u00f3 th\u1ec3 bi\u1ebfn nh\u1eefng kho\u1ea3n \u0111\u1ea7u t\u01b0 khi\u00eam t\u1ed1n th\u00e0nh l\u1ee3i nhu\u1eadn thay \u0111\u1ed5i cu\u1ed9c s\u1ed1ng. V\u1edbi n\u1ec1n t\u1ea3ng li\u00ean k\u1ebft thu\u1ed1c-kh\u00e1ng th\u1ec3 \u0111\u1ea7y tri\u1ec3n v\u1ecdng v\u00e0 quan h\u1ec7 \u0111\u1ed1i t\u00e1c chi\u1ebfn l\u01b0\u1ee3c v\u1edbi Merck, c\u00f4ng ty n\u00e0y mang \u0111\u1ebfn c\u1ea3 r\u1ee7i ro cao v\u00e0 ph\u1ea7n th\u01b0\u1edfng ti\u1ec1m n\u0103ng phi th\u01b0\u1eddng cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 th\u00f4ng minh.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb ung th\u01b0 \u0111\u1ed9t ph\u00e1 ti\u1ebfp theo? Pyxis Oncology \u0111\u1ea1i di\u1ec7n cho th\u1ebf gi\u1edbi \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ea7y h\u1ee9ng kh\u1edfi, n\u01a1i th\u00e0nh c\u00f4ng trong c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng c\u00f3 th\u1ec3 bi\u1ebfn nh\u1eefng kho\u1ea3n \u0111\u1ea7u t\u01b0 khi\u00eam t\u1ed1n th\u00e0nh l\u1ee3i nhu\u1eadn thay \u0111\u1ed5i cu\u1ed9c s\u1ed1ng. V\u1edbi n\u1ec1n t\u1ea3ng li\u00ean k\u1ebft thu\u1ed1c-kh\u00e1ng th\u1ec3 \u0111\u1ea7y tri\u1ec3n v\u1ecdng v\u00e0 quan h\u1ec7 \u0111\u1ed1i t\u00e1c chi\u1ebfn l\u01b0\u1ee3c v\u1edbi Merck, c\u00f4ng ty n\u00e0y mang \u0111\u1ebfn c\u1ea3 r\u1ee7i ro cao v\u00e0 ph\u1ea7n th\u01b0\u1edfng ti\u1ec1m n\u0103ng phi th\u01b0\u1eddng cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 th\u00f4ng minh."},"body_html":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Pyxis Oncology: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 24 th\u00e1ng 8 n\u0103m 2025, Pyxis Oncology (PYXS) giao d\u1ecbch \u1edf m\u1ee9c <strong>1,24 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>11 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng \u2014 \u0111\u00f3 l\u00e0 khi Pyxis c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd ti\u1ebfp theo.<\/p> <h3>C\u00e1ch B\u00e1o C\u00e1o Thu Nh\u1eadp \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu PYXS<\/h3> <p>Ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc s\u1ed1ng v\u00e0 ch\u1ebft d\u1ef1a v\u00e0o c\u00e1c c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 k\u1ebft qu\u1ea3 t\u00e0i ch\u00ednh. Nh\u00ecn v\u00e0o l\u1ecbch s\u1eed g\u1ea7n \u0111\u00e2y:<\/p> <table> <thead> <tr><th>Ng\u00e0y<\/th><th>S\u1ef1 ki\u1ec7n<\/th><th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th><th>Thay \u0110\u1ed5i Sau Tin<\/th><\/tr> <\/thead> <tbody> <tr><td>14 th\u00e1ng 8, 2025<\/td><td>B\u00e1o c\u00e1o Q2<\/td><td>1,18 USD<\/td><td>+5,1% (ph\u1ea3n \u1ee9ng h\u1ed7n h\u1ee3p)<\/td><\/tr> <tr><td>Th\u00e1ng 5, 2025<\/td><td>D\u1eef li\u1ec7u H\u1ed9i ngh\u1ecb AACR<\/td><td>0,95 USD<\/td><td>+31,6% (d\u1eef li\u1ec7u t\u00edch c\u1ef1c)<\/td><\/tr> <tr><td>Th\u00e1ng 2, 2025<\/td><td>Quan h\u1ec7 \u0111\u1ed1i t\u00e1c Merck<\/td><td>1,05 USD<\/td><td>+18,1% (th\u1eafng l\u1ee3i chi\u1ebfn l\u01b0\u1ee3c)<\/td><\/tr> <tr><td>Th\u00e1ng 11, 2024<\/td><td>D\u1eef li\u1ec7u giai \u0111o\u1ea1n 1 ban \u0111\u1ea7u<\/td><td>1,20 USD<\/td><td>-15,0% (k\u1ebft qu\u1ea3 th\u1ea5t v\u1ecdng)<\/td><\/tr> <tr><td>Th\u00e1ng 8, 2024<\/td><td>Thay \u0111\u1ed5i l\u00e3nh \u0111\u1ea1o<\/td><td>1,35 USD<\/td><td>-8,9% (b\u1ea5t \u1ed5n)<\/td><\/tr> <tr><td>Th\u00e1ng 5, 2024<\/td><td>C\u1eadp nh\u1eadt ti\u1ec1n l\u00e2m s\u00e0ng<\/td><td>1,10 USD<\/td><td>+22,7% (khoa h\u1ecdc \u0111\u1ea7y h\u1ee9a h\u1eb9n)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Nh\u1eadn \u0111\u1ecbnh xu h\u01b0\u1edbng<\/strong>: D\u1eef li\u1ec7u l\u00e2m s\u00e0ng t\u00edch c\u1ef1c (nh\u01b0 AACR 2025) t\u1ea1o ra nh\u1eefng b\u01b0\u1edbc nh\u1ea3y v\u1ecdt m\u1ea1nh m\u1ebd, trong khi b\u1ea5t k\u1ef3 k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m ti\u00eau c\u1ef1c n\u00e0o c\u0169ng g\u00e2y ra s\u1ee5t gi\u1ea3m ngay l\u1eadp t\u1ee9c t\u1eeb 15-20%. Quan h\u1ec7 \u0111\u1ed1i t\u00e1c v\u1edbi Merck \u0111\u00e3 cung c\u1ea5p \u0111\u1ed9ng l\u1ef1c b\u1ec1n v\u1eefng, cho th\u1ea5y c\u00e1c th\u1ecfa thu\u1eadn chi\u1ebfn l\u01b0\u1ee3c quan tr\u1ecdng kh\u00f4ng k\u00e9m g\u00ec khoa h\u1ecdc.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udd04 H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 2 - Th\u00e1ng 8, 2025)<\/h2> <p>C\u1ed5 phi\u1ebfu Pyxis \u0111\u00e3 tr\u1ea3i qua m\u1ed9t chuy\u1ebfn t\u00e0u l\u01b0\u1ee3n si\u00eau t\u1ed1c:<\/p> <p><strong>Th\u00e1ng 2<\/strong>: 1,05 USD (h\u1ee9ng kh\u1edfi v\u1edbi quan h\u1ec7 \u0111\u1ed1i t\u00e1c Merck)<br> <strong>Th\u00e1ng 3<\/strong>: 0,88 USD (\u0111i\u1ec1u ch\u1ec9nh th\u1ecb tr\u01b0\u1eddng, ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc y\u1ebfu)<br> <strong>Th\u00e1ng 4<\/strong>: 0,92 USD (h\u1ed3i ph\u1ee5c d\u1ea7n, k\u1ef3 v\u1ecdng AACR)<br> <strong>Th\u00e1ng 5<\/strong>: 1,25 USD (d\u1eef li\u1ec7u t\u00edch c\u1ef1c AACR, t\u0103ng 31,6%)<br> <strong>Th\u00e1ng 6<\/strong>: 1,18 USD (ch\u1ed1t l\u1eddi, lu\u00e2n chuy\u1ec3n ng\u00e0nh)<br> <strong>Th\u00e1ng 7<\/strong>: 1,15 USD (m\u00f9a h\u00e8 \u1ea3m \u0111\u1ea1m, kh\u1ed1i l\u01b0\u1ee3ng th\u1ea5p)<br> <strong>Th\u00e1ng 8<\/strong>: 1,24 USD (\u1ed5n \u0111\u1ecbnh b\u00e1o c\u00e1o Q2)<\/p> <p>C\u1ed5 phi\u1ebfu \u0111\u00e3 t\u0103ng kho\u1ea3ng <strong>18%<\/strong> trong giai \u0111o\u1ea1n bi\u1ebfn \u0111\u1ed9ng n\u00e0y, nh\u01b0ng c\u00e2u chuy\u1ec7n th\u1ef1c s\u1ef1 l\u00e0 s\u1ef1 bi\u1ebfn \u0111\u1ed9ng c\u1ef1c \u0111oan \u2014 nh\u1eefng bi\u1ebfn \u0111\u1ed9ng tr\u00ean 30% trong m\u1ed9t th\u00e1ng l\u00e0 \u0111i\u1ec1u th\u01b0\u1eddng th\u1ea5y trong l\u0129nh v\u1ef1c n\u00e0y.<\/p> <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean d\u1ef1 b\u00e1o hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 ti\u1ebfn tri\u1ec3n trong pipeline l\u00e2m s\u00e0ng:<\/p> <p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 2,50-3,00 USD (ch\u1edd c\u1eadp nh\u1eadt l\u00e2m s\u00e0ng th\u00e1ng 11) \u2192 <strong>MUA<\/strong><br> <strong>2026<\/strong>: 4,00-6,00 USD (d\u1eef li\u1ec7u giai \u0111o\u1ea1n 2 d\u1ef1 ki\u1ebfn, kh\u1ea3 n\u0103ng h\u1ee3p t\u00e1c)<br> <strong>2028<\/strong>: 8,00-12,00 USD (kh\u1edfi \u0111\u1ea7u giai \u0111o\u1ea1n 3, c\u00e1c m\u1ed1c ph\u00e1p l\u00fd)<br> <strong>2030<\/strong>: 15,00-20,00 USD (ti\u1ec1m n\u0103ng th\u01b0\u01a1ng m\u1ea1i h\u00f3a, t\u1ea1o doanh thu)<\/p> <p><strong>K\u1ebft lu\u1eadn<\/strong>: Mua m\u1ea1nh cho nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu r\u1ee7i ro v\u1edbi t\u1ea7m nh\u00ecn 2-5 n\u0103m. M\u1ee5c ti\u00eau gi\u00e1 \u0111\u1ed3ng thu\u1eadn hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch l\u00e0 <a href=\"https:\/\/stockanalysis.com\/stocks\/pyxs\/forecast\/\">8,67 USD, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng ti\u1ec1m n\u0103ng t\u0103ng tr\u00ean 600%<\/a>.<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3> <ul> <li><a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-pyxs\/pyxis-oncology\/news\/heres-why-were-watching-pyxis-oncologys-nasdaqpyxs-cash-burn-1\">Ch\u1ec9 c\u00f2n 21 th\u00e1ng ti\u1ec1n m\u1eb7t<\/a> theo t\u1ed1c \u0111\u1ed9 ti\u00eau hi\u1ec7n t\u1ea1i<\/li> <li>Th\u1ea5t b\u1ea1i l\u00e2m s\u00e0ng: B\u1ea5t k\u1ef3 d\u1eef li\u1ec7u th\u1eed nghi\u1ec7m ti\u00eau c\u1ef1c n\u00e0o c\u0169ng c\u00f3 th\u1ec3 khi\u1ebfn c\u1ed5 phi\u1ebfu gi\u1ea3m h\u01a1n 50% ngay l\u1eadp t\u1ee9c<\/li> <li>R\u1ee7i ro pha lo\u00e3ng: Kh\u1ea3 n\u0103ng cao s\u1ebd c\u00f3 \u0111\u1ee3t ph\u00e1t h\u00e0nh th\u00eam \u0111\u1ec3 t\u00e0i tr\u1ee3 ho\u1ea1t \u0111\u1ed9ng<\/li> <li>Bi\u1ebfn \u0111\u1ed9ng ng\u00e0nh: C\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u01b0\u1eddng bi\u1ebfn \u0111\u1ed9ng g\u1ea5p 3-5 l\u1ea7n th\u1ecb tr\u01b0\u1eddng chung<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u Xanh Cho 2025-2026<\/h3> <ul> <li><a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/02\/04\/3020191\/0\/en\/Pyxis-Oncology-Initiates-New-PYX-201-Combination-Trial-and-Initiates-Cohort-Expansions-of-Ongoing-Monotherapy-Trial.html\">Nghi\u00ean c\u1ee9u k\u1ebft h\u1ee3p giai \u0111o\u1ea1n 1\/2 v\u1edbi KEYTRUDA<\/a> \u0111ang tuy\u1ec3n d\u1ee5ng t\u00edch c\u1ef1c<\/li> <li><a href=\"https:\/\/www.quiverquant.com\/news\/Pyxis+Oncology+Highlights+Promising+Preclinical+Data+for+Micvotabart+Pelidotin+(MICVO)+in+Cancer+Therapy+at+AACR+2025\">K\u1ebft qu\u1ea3 ti\u1ec1n l\u00e2m s\u00e0ng \u0111\u1ea7y h\u1ee9a h\u1eb9n t\u1ea1i AACR 2025<\/a> cho MICVO<\/li> <li>H\u1ed7 tr\u1ee3 t\u1eeb nh\u00e0 ph\u00e2n t\u00edch: 3 \u0111\u00e1nh gi\u00e1 mua, m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh 8,67 USD<\/li> <li>V\u1ecb th\u1ebf th\u1ecb tr\u01b0\u1eddng: Li\u00ean k\u1ebft thu\u1ed1c-kh\u00e1ng th\u1ec3 \u0111\u1ea7u ti\u00ean trong l\u1edbp nh\u1eafm v\u00e0o kh\u1ed1i u r\u1eafn<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong> - Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 2-3% danh m\u1ee5c cho c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li> <li><strong>S\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n<\/strong> - Kh\u00f4ng bao gi\u1edd d\u00f9ng l\u1ec7nh th\u1ecb tr\u01b0\u1eddng v\u1edbi c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng nh\u01b0 PYXS<\/li> <li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o<\/strong> - Theo d\u00f5i b\u00e1o c\u00e1o thu nh\u1eadp ng\u00e0y 11 th\u00e1ng 11 v\u00e0 c\u00e1c th\u00f4ng b\u00e1o th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/li> <li><strong>\u0110a d\u1ea1ng th\u1eddi \u0111i\u1ec3m mua<\/strong> - C\u00e2n nh\u1eafc mua chia l\u00e0m ba ph\u1ea7n trong 3 th\u00e1ng t\u1edbi \u0111\u1ec3 trung b\u00ecnh gi\u00e1 v\u00e0o<\/li> <\/ol> <p>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc: \"Giao d\u1ecbch PYXS gi\u1ed1ng nh\u01b0 xem m\u1ed9t b\u1ed9 phim y khoa \u2014 b\u1ea1n c\u1ea7n th\u1ea7n kinh th\u00e9p cho nh\u1eefng c\u00fa plot twist, nh\u01b0ng t\u1eadp cu\u1ed1i c\u00f3 th\u1ec3 r\u1ea5t ngo\u1ea1n m\u1ee5c!\"<\/p> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Pyxis Oncology, Inc. (PYXS) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng c\u00f3 danh s\u00e1ch NASDAQ v\u00e0 h\u1ed7 tr\u1ee3 c\u1ed5 phi\u1ebfu l\u1ebb<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n<\/td><td>H\u1ea7u h\u1ebft n\u1ec1n t\u1ea3ng y\u00eau c\u1ea7u ID v\u00e0 b\u1eb1ng ch\u1ee9ng \u0111\u1ecba ch\u1ec9<\/td><\/tr> <tr><td>3<\/td><td>N\u1ea1p ti\u1ec1n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n s\u1eb5n s\u00e0ng ch\u1ecbu m\u1ea5t ho\u00e0n to\u00e0n<\/td><\/tr> <tr><td>4<\/td><td>T\u00ecm ki\u1ebfm \"PYXS\"<\/td><td>D\u00f9ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng d\u00f9ng t\u00ean c\u00f4ng ty<\/td><\/tr> <tr><td>5<\/td><td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td><td>D\u00f9ng l\u1ec7nh GI\u1edaI H\u1ea0N \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o<\/td><\/tr> <tr><td>6<\/td><td>\u0110\u1eb7t s\u1ed1 l\u01b0\u1ee3ng c\u1ed5 phi\u1ebfu<\/td><td>C\u00e2n nh\u1eafc c\u1ed5 phi\u1ebfu l\u1ebb n\u1ebfu c\u1ed5 phi\u1ebfu nguy\u00ean qu\u00e1 \u0111\u1eaft<\/td><\/tr> <tr><td>7<\/td><td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td><td>Ki\u1ec3m tra k\u1ef9 th\u00f4ng tin l\u1ec7nh tr\u01b0\u1edbc khi g\u1eedi<\/td><\/tr> <tr><td>8<\/td><td>Gi\u00e1m s\u00e1t v\u1ecb th\u1ebf<\/td><td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 c\u1ea3 cho c\u1ea3 chi\u1ec1u t\u0103ng v\u00e0 gi\u1ea3m<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ai quan t\u00e2m \u0111\u1ebfn c\u00e1c c\u00f4ng ty nh\u01b0 Pyxis Oncology, Pocket Option mang l\u1ea1i nhi\u1ec1u l\u1ee3i th\u1ebf:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong> - Ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi v\u1ecb th\u1ebf nh\u1ecf trong c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng<\/li> <li><strong>X\u00e1c minh nhanh ch\u00f3ng<\/strong> - Quy tr\u00ecnh KYC ch\u1ec9 c\u1ea7n m\u1ed9t t\u00e0i li\u1ec7u gi\u00fap b\u1ea1n giao d\u1ecbch nhanh ch\u00f3ng<\/li> <li><strong>C\u1ed5 phi\u1ebfu l\u1ebb<\/strong> - Mua ph\u1ea7n nh\u1ecf c\u1ee7a c\u1ed5 phi\u1ebfu \u0111\u1eaft ti\u1ec1n m\u00e0 kh\u00f4ng c\u1ea7n mua nguy\u00ean c\u1ed5 phi\u1ebfu<\/li> <li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> - Linh ho\u1ea1t ti\u1ebfp c\u1eadn l\u1ee3i nhu\u1eadn qua nhi\u1ec1u k\u00eanh<\/li> <\/ul> <h2>\ud83c\udf0d Pyxis Oncology N\u0103m 2025: Nh\u00e0 \u0110\u1ed5i M\u1edbi \u0110i\u1ec1u Tr\u1ecb Ung Th\u01b0<\/h2> <p>Pyxis Oncology \u0111ang c\u00e1ch m\u1ea1ng h\u00f3a \u0111i\u1ec1u tr\u1ecb ung th\u01b0 v\u1edbi n\u1ec1n t\u1ea3ng li\u00ean k\u1ebft thu\u1ed1c-kh\u00e1ng th\u1ec3 s\u00e1ng t\u1ea1o nh\u1eafm v\u00e0o c\u00e1c kh\u1ed1i u r\u1eafn. \u1ee8ng vi\u00ean h\u00e0ng \u0111\u1ea7u c\u1ee7a c\u00f4ng ty, MICVO (tr\u01b0\u1edbc \u0111\u00e2y l\u00e0 PYX-201), \u0111\u1ea1i di\u1ec7n cho ph\u01b0\u01a1ng ph\u00e1p \u0111\u1ea7u ti\u00ean trong l\u1edbp c\u00f3 th\u1ec3 thay \u0111\u1ed5i c\u00e1ch ch\u00fang ta \u0111i\u1ec1u tr\u1ecb ung th\u01b0 \u0111\u1ea7u v\u00e0 c\u1ed5 t\u00e1i ph\u00e1t.<\/p> <p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025<\/strong>: C\u00e1c nh\u00e0 khoa h\u1ecdc Pyxis ph\u00e1t hi\u1ec7n n\u1ec1n t\u1ea3ng kh\u00e1ng th\u1ec3 c\u1ee7a h\u1ecd v\u00f4 t\u00ecnh ho\u1ea1t \u0111\u1ed9ng t\u1ed1t h\u01a1n khi k\u1ebft h\u1ee3p v\u1edbi c\u00e1c li\u1ec7u ph\u00e1p hi\u1ec7n c\u00f3 \u2014 d\u1eabn \u0111\u1ebfn quan h\u1ec7 \u0111\u1ed1i t\u00e1c chi\u1ebfn l\u01b0\u1ee3c v\u1edbi Merck m\u00e0 c\u00f3 th\u1ec3 kh\u00f4ng x\u1ea3y ra n\u1ebfu kh\u00f4ng c\u00f3 s\u1ef1 t\u00ecnh c\u1edd may m\u1eafn n\u00e0y!<\/p> <p>\u0110\u1ec3 bi\u1ebft th\u00eam th\u00f4ng tin v\u1ec1 chi\u1ebfn l\u01b0\u1ee3c giao d\u1ecbch v\u00e0 ph\u00e2n t\u00edch th\u1ecb tr\u01b0\u1eddng, h\u00e3y truy c\u1eadp <a href=\"\/blog\">blog Pocket Option<\/a> v\u1edbi n\u1ed9i dung gi\u00e1o d\u1ee5c d\u00e0nh cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Pyxis Oncology: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 24 th\u00e1ng 8 n\u0103m 2025, Pyxis Oncology (PYXS) giao d\u1ecbch \u1edf m\u1ee9c <strong>1,24 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>11 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng \u2014 \u0111\u00f3 l\u00e0 khi Pyxis c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd ti\u1ebfp theo.<\/p>\n<h3>C\u00e1ch B\u00e1o C\u00e1o Thu Nh\u1eadp \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu PYXS<\/h3>\n<p>Ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc s\u1ed1ng v\u00e0 ch\u1ebft d\u1ef1a v\u00e0o c\u00e1c c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 k\u1ebft qu\u1ea3 t\u00e0i ch\u00ednh. Nh\u00ecn v\u00e0o l\u1ecbch s\u1eed g\u1ea7n \u0111\u00e2y:<\/p>\n<table>\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th>\n<th>Thay \u0110\u1ed5i Sau Tin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>14 th\u00e1ng 8, 2025<\/td>\n<td>B\u00e1o c\u00e1o Q2<\/td>\n<td>1,18 USD<\/td>\n<td>+5,1% (ph\u1ea3n \u1ee9ng h\u1ed7n h\u1ee3p)<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 5, 2025<\/td>\n<td>D\u1eef li\u1ec7u H\u1ed9i ngh\u1ecb AACR<\/td>\n<td>0,95 USD<\/td>\n<td>+31,6% (d\u1eef li\u1ec7u t\u00edch c\u1ef1c)<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 2, 2025<\/td>\n<td>Quan h\u1ec7 \u0111\u1ed1i t\u00e1c Merck<\/td>\n<td>1,05 USD<\/td>\n<td>+18,1% (th\u1eafng l\u1ee3i chi\u1ebfn l\u01b0\u1ee3c)<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 11, 2024<\/td>\n<td>D\u1eef li\u1ec7u giai \u0111o\u1ea1n 1 ban \u0111\u1ea7u<\/td>\n<td>1,20 USD<\/td>\n<td>-15,0% (k\u1ebft qu\u1ea3 th\u1ea5t v\u1ecdng)<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 8, 2024<\/td>\n<td>Thay \u0111\u1ed5i l\u00e3nh \u0111\u1ea1o<\/td>\n<td>1,35 USD<\/td>\n<td>-8,9% (b\u1ea5t \u1ed5n)<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 5, 2024<\/td>\n<td>C\u1eadp nh\u1eadt ti\u1ec1n l\u00e2m s\u00e0ng<\/td>\n<td>1,10 USD<\/td>\n<td>+22,7% (khoa h\u1ecdc \u0111\u1ea7y h\u1ee9a h\u1eb9n)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Nh\u1eadn \u0111\u1ecbnh xu h\u01b0\u1edbng<\/strong>: D\u1eef li\u1ec7u l\u00e2m s\u00e0ng t\u00edch c\u1ef1c (nh\u01b0 AACR 2025) t\u1ea1o ra nh\u1eefng b\u01b0\u1edbc nh\u1ea3y v\u1ecdt m\u1ea1nh m\u1ebd, trong khi b\u1ea5t k\u1ef3 k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m ti\u00eau c\u1ef1c n\u00e0o c\u0169ng g\u00e2y ra s\u1ee5t gi\u1ea3m ngay l\u1eadp t\u1ee9c t\u1eeb 15-20%. Quan h\u1ec7 \u0111\u1ed1i t\u00e1c v\u1edbi Merck \u0111\u00e3 cung c\u1ea5p \u0111\u1ed9ng l\u1ef1c b\u1ec1n v\u1eefng, cho th\u1ea5y c\u00e1c th\u1ecfa thu\u1eadn chi\u1ebfn l\u01b0\u1ee3c quan tr\u1ecdng kh\u00f4ng k\u00e9m g\u00ec khoa h\u1ecdc.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 2 &#8211; Th\u00e1ng 8, 2025)<\/h2>\n<p>C\u1ed5 phi\u1ebfu Pyxis \u0111\u00e3 tr\u1ea3i qua m\u1ed9t chuy\u1ebfn t\u00e0u l\u01b0\u1ee3n si\u00eau t\u1ed1c:<\/p>\n<p><strong>Th\u00e1ng 2<\/strong>: 1,05 USD (h\u1ee9ng kh\u1edfi v\u1edbi quan h\u1ec7 \u0111\u1ed1i t\u00e1c Merck)<br \/> <strong>Th\u00e1ng 3<\/strong>: 0,88 USD (\u0111i\u1ec1u ch\u1ec9nh th\u1ecb tr\u01b0\u1eddng, ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc y\u1ebfu)<br \/> <strong>Th\u00e1ng 4<\/strong>: 0,92 USD (h\u1ed3i ph\u1ee5c d\u1ea7n, k\u1ef3 v\u1ecdng AACR)<br \/> <strong>Th\u00e1ng 5<\/strong>: 1,25 USD (d\u1eef li\u1ec7u t\u00edch c\u1ef1c AACR, t\u0103ng 31,6%)<br \/> <strong>Th\u00e1ng 6<\/strong>: 1,18 USD (ch\u1ed1t l\u1eddi, lu\u00e2n chuy\u1ec3n ng\u00e0nh)<br \/> <strong>Th\u00e1ng 7<\/strong>: 1,15 USD (m\u00f9a h\u00e8 \u1ea3m \u0111\u1ea1m, kh\u1ed1i l\u01b0\u1ee3ng th\u1ea5p)<br \/> <strong>Th\u00e1ng 8<\/strong>: 1,24 USD (\u1ed5n \u0111\u1ecbnh b\u00e1o c\u00e1o Q2)<\/p>\n<p>C\u1ed5 phi\u1ebfu \u0111\u00e3 t\u0103ng kho\u1ea3ng <strong>18%<\/strong> trong giai \u0111o\u1ea1n bi\u1ebfn \u0111\u1ed9ng n\u00e0y, nh\u01b0ng c\u00e2u chuy\u1ec7n th\u1ef1c s\u1ef1 l\u00e0 s\u1ef1 bi\u1ebfn \u0111\u1ed9ng c\u1ef1c \u0111oan \u2014 nh\u1eefng bi\u1ebfn \u0111\u1ed9ng tr\u00ean 30% trong m\u1ed9t th\u00e1ng l\u00e0 \u0111i\u1ec1u th\u01b0\u1eddng th\u1ea5y trong l\u0129nh v\u1ef1c n\u00e0y.<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean d\u1ef1 b\u00e1o hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 ti\u1ebfn tri\u1ec3n trong pipeline l\u00e2m s\u00e0ng:<\/p>\n<p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 2,50-3,00 USD (ch\u1edd c\u1eadp nh\u1eadt l\u00e2m s\u00e0ng th\u00e1ng 11) \u2192 <strong>MUA<\/strong><br \/> <strong>2026<\/strong>: 4,00-6,00 USD (d\u1eef li\u1ec7u giai \u0111o\u1ea1n 2 d\u1ef1 ki\u1ebfn, kh\u1ea3 n\u0103ng h\u1ee3p t\u00e1c)<br \/> <strong>2028<\/strong>: 8,00-12,00 USD (kh\u1edfi \u0111\u1ea7u giai \u0111o\u1ea1n 3, c\u00e1c m\u1ed1c ph\u00e1p l\u00fd)<br \/> <strong>2030<\/strong>: 15,00-20,00 USD (ti\u1ec1m n\u0103ng th\u01b0\u01a1ng m\u1ea1i h\u00f3a, t\u1ea1o doanh thu)<\/p>\n<p><strong>K\u1ebft lu\u1eadn<\/strong>: Mua m\u1ea1nh cho nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu r\u1ee7i ro v\u1edbi t\u1ea7m nh\u00ecn 2-5 n\u0103m. M\u1ee5c ti\u00eau gi\u00e1 \u0111\u1ed3ng thu\u1eadn hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch l\u00e0 <a href=\"https:\/\/stockanalysis.com\/stocks\/pyxs\/forecast\/\">8,67 USD, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng ti\u1ec1m n\u0103ng t\u0103ng tr\u00ean 600%<\/a>.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3>\n<ul>\n<li><a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-pyxs\/pyxis-oncology\/news\/heres-why-were-watching-pyxis-oncologys-nasdaqpyxs-cash-burn-1\">Ch\u1ec9 c\u00f2n 21 th\u00e1ng ti\u1ec1n m\u1eb7t<\/a> theo t\u1ed1c \u0111\u1ed9 ti\u00eau hi\u1ec7n t\u1ea1i<\/li>\n<li>Th\u1ea5t b\u1ea1i l\u00e2m s\u00e0ng: B\u1ea5t k\u1ef3 d\u1eef li\u1ec7u th\u1eed nghi\u1ec7m ti\u00eau c\u1ef1c n\u00e0o c\u0169ng c\u00f3 th\u1ec3 khi\u1ebfn c\u1ed5 phi\u1ebfu gi\u1ea3m h\u01a1n 50% ngay l\u1eadp t\u1ee9c<\/li>\n<li>R\u1ee7i ro pha lo\u00e3ng: Kh\u1ea3 n\u0103ng cao s\u1ebd c\u00f3 \u0111\u1ee3t ph\u00e1t h\u00e0nh th\u00eam \u0111\u1ec3 t\u00e0i tr\u1ee3 ho\u1ea1t \u0111\u1ed9ng<\/li>\n<li>Bi\u1ebfn \u0111\u1ed9ng ng\u00e0nh: C\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u01b0\u1eddng bi\u1ebfn \u0111\u1ed9ng g\u1ea5p 3-5 l\u1ea7n th\u1ecb tr\u01b0\u1eddng chung<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u Xanh Cho 2025-2026<\/h3>\n<ul>\n<li><a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/02\/04\/3020191\/0\/en\/Pyxis-Oncology-Initiates-New-PYX-201-Combination-Trial-and-Initiates-Cohort-Expansions-of-Ongoing-Monotherapy-Trial.html\">Nghi\u00ean c\u1ee9u k\u1ebft h\u1ee3p giai \u0111o\u1ea1n 1\/2 v\u1edbi KEYTRUDA<\/a> \u0111ang tuy\u1ec3n d\u1ee5ng t\u00edch c\u1ef1c<\/li>\n<li><a href=\"https:\/\/www.quiverquant.com\/news\/Pyxis+Oncology+Highlights+Promising+Preclinical+Data+for+Micvotabart+Pelidotin+(MICVO)+in+Cancer+Therapy+at+AACR+2025\">K\u1ebft qu\u1ea3 ti\u1ec1n l\u00e2m s\u00e0ng \u0111\u1ea7y h\u1ee9a h\u1eb9n t\u1ea1i AACR 2025<\/a> cho MICVO<\/li>\n<li>H\u1ed7 tr\u1ee3 t\u1eeb nh\u00e0 ph\u00e2n t\u00edch: 3 \u0111\u00e1nh gi\u00e1 mua, m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh 8,67 USD<\/li>\n<li>V\u1ecb th\u1ebf th\u1ecb tr\u01b0\u1eddng: Li\u00ean k\u1ebft thu\u1ed1c-kh\u00e1ng th\u1ec3 \u0111\u1ea7u ti\u00ean trong l\u1edbp nh\u1eafm v\u00e0o kh\u1ed1i u r\u1eafn<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong> &#8211; Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 2-3% danh m\u1ee5c cho c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li>\n<li><strong>S\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n<\/strong> &#8211; Kh\u00f4ng bao gi\u1edd d\u00f9ng l\u1ec7nh th\u1ecb tr\u01b0\u1eddng v\u1edbi c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng nh\u01b0 PYXS<\/li>\n<li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o<\/strong> &#8211; Theo d\u00f5i b\u00e1o c\u00e1o thu nh\u1eadp ng\u00e0y 11 th\u00e1ng 11 v\u00e0 c\u00e1c th\u00f4ng b\u00e1o th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/li>\n<li><strong>\u0110a d\u1ea1ng th\u1eddi \u0111i\u1ec3m mua<\/strong> &#8211; C\u00e2n nh\u1eafc mua chia l\u00e0m ba ph\u1ea7n trong 3 th\u00e1ng t\u1edbi \u0111\u1ec3 trung b\u00ecnh gi\u00e1 v\u00e0o<\/li>\n<\/ol>\n<p>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc: &#8220;Giao d\u1ecbch PYXS gi\u1ed1ng nh\u01b0 xem m\u1ed9t b\u1ed9 phim y khoa \u2014 b\u1ea1n c\u1ea7n th\u1ea7n kinh th\u00e9p cho nh\u1eefng c\u00fa plot twist, nh\u01b0ng t\u1eadp cu\u1ed1i c\u00f3 th\u1ec3 r\u1ea5t ngo\u1ea1n m\u1ee5c!&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Pyxis Oncology, Inc. (PYXS) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng c\u00f3 danh s\u00e1ch NASDAQ v\u00e0 h\u1ed7 tr\u1ee3 c\u1ed5 phi\u1ebfu l\u1ebb<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n<\/td>\n<td>H\u1ea7u h\u1ebft n\u1ec1n t\u1ea3ng y\u00eau c\u1ea7u ID v\u00e0 b\u1eb1ng ch\u1ee9ng \u0111\u1ecba ch\u1ec9<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>N\u1ea1p ti\u1ec1n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n s\u1eb5n s\u00e0ng ch\u1ecbu m\u1ea5t ho\u00e0n to\u00e0n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;PYXS&#8221;<\/td>\n<td>D\u00f9ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng d\u00f9ng t\u00ean c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td>\n<td>D\u00f9ng l\u1ec7nh GI\u1edaI H\u1ea0N \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0110\u1eb7t s\u1ed1 l\u01b0\u1ee3ng c\u1ed5 phi\u1ebfu<\/td>\n<td>C\u00e2n nh\u1eafc c\u1ed5 phi\u1ebfu l\u1ebb n\u1ebfu c\u1ed5 phi\u1ebfu nguy\u00ean qu\u00e1 \u0111\u1eaft<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td>\n<td>Ki\u1ec3m tra k\u1ef9 th\u00f4ng tin l\u1ec7nh tr\u01b0\u1edbc khi g\u1eedi<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Gi\u00e1m s\u00e1t v\u1ecb th\u1ebf<\/td>\n<td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 c\u1ea3 cho c\u1ea3 chi\u1ec1u t\u0103ng v\u00e0 gi\u1ea3m<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ai quan t\u00e2m \u0111\u1ebfn c\u00e1c c\u00f4ng ty nh\u01b0 Pyxis Oncology, Pocket Option mang l\u1ea1i nhi\u1ec1u l\u1ee3i th\u1ebf:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong> &#8211; Ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi v\u1ecb th\u1ebf nh\u1ecf trong c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng<\/li>\n<li><strong>X\u00e1c minh nhanh ch\u00f3ng<\/strong> &#8211; Quy tr\u00ecnh KYC ch\u1ec9 c\u1ea7n m\u1ed9t t\u00e0i li\u1ec7u gi\u00fap b\u1ea1n giao d\u1ecbch nhanh ch\u00f3ng<\/li>\n<li><strong>C\u1ed5 phi\u1ebfu l\u1ebb<\/strong> &#8211; Mua ph\u1ea7n nh\u1ecf c\u1ee7a c\u1ed5 phi\u1ebfu \u0111\u1eaft ti\u1ec1n m\u00e0 kh\u00f4ng c\u1ea7n mua nguy\u00ean c\u1ed5 phi\u1ebfu<\/li>\n<li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> &#8211; Linh ho\u1ea1t ti\u1ebfp c\u1eadn l\u1ee3i nhu\u1eadn qua nhi\u1ec1u k\u00eanh<\/li>\n<\/ul>\n<h2>\ud83c\udf0d Pyxis Oncology N\u0103m 2025: Nh\u00e0 \u0110\u1ed5i M\u1edbi \u0110i\u1ec1u Tr\u1ecb Ung Th\u01b0<\/h2>\n<p>Pyxis Oncology \u0111ang c\u00e1ch m\u1ea1ng h\u00f3a \u0111i\u1ec1u tr\u1ecb ung th\u01b0 v\u1edbi n\u1ec1n t\u1ea3ng li\u00ean k\u1ebft thu\u1ed1c-kh\u00e1ng th\u1ec3 s\u00e1ng t\u1ea1o nh\u1eafm v\u00e0o c\u00e1c kh\u1ed1i u r\u1eafn. \u1ee8ng vi\u00ean h\u00e0ng \u0111\u1ea7u c\u1ee7a c\u00f4ng ty, MICVO (tr\u01b0\u1edbc \u0111\u00e2y l\u00e0 PYX-201), \u0111\u1ea1i di\u1ec7n cho ph\u01b0\u01a1ng ph\u00e1p \u0111\u1ea7u ti\u00ean trong l\u1edbp c\u00f3 th\u1ec3 thay \u0111\u1ed5i c\u00e1ch ch\u00fang ta \u0111i\u1ec1u tr\u1ecb ung th\u01b0 \u0111\u1ea7u v\u00e0 c\u1ed5 t\u00e1i ph\u00e1t.<\/p>\n<p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025<\/strong>: C\u00e1c nh\u00e0 khoa h\u1ecdc Pyxis ph\u00e1t hi\u1ec7n n\u1ec1n t\u1ea3ng kh\u00e1ng th\u1ec3 c\u1ee7a h\u1ecd v\u00f4 t\u00ecnh ho\u1ea1t \u0111\u1ed9ng t\u1ed1t h\u01a1n khi k\u1ebft h\u1ee3p v\u1edbi c\u00e1c li\u1ec7u ph\u00e1p hi\u1ec7n c\u00f3 \u2014 d\u1eabn \u0111\u1ebfn quan h\u1ec7 \u0111\u1ed1i t\u00e1c chi\u1ebfn l\u01b0\u1ee3c v\u1edbi Merck m\u00e0 c\u00f3 th\u1ec3 kh\u00f4ng x\u1ea3y ra n\u1ebfu kh\u00f4ng c\u00f3 s\u1ef1 t\u00ecnh c\u1edd may m\u1eafn n\u00e0y!<\/p>\n<p>\u0110\u1ec3 bi\u1ebft th\u00eam th\u00f4ng tin v\u1ec1 chi\u1ebfn l\u01b0\u1ee3c giao d\u1ecbch v\u00e0 ph\u00e2n t\u00edch th\u1ecb tr\u01b0\u1eddng, h\u00e3y truy c\u1eadp <a href=\"\/blog\">blog Pocket Option<\/a> v\u1edbi n\u1ed9i dung gi\u00e1o d\u1ee5c d\u00e0nh cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi.<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u mua c\u1ed5 phi\u1ebfu Pyxis Oncology (PYXS)?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb, ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 PYXS, ch\u1ecdn lo\u1ea1i l\u1ec7nh gi\u1edbi h\u1ea1n, \u0111\u1eb7t s\u1ed1 l\u01b0\u1ee3ng c\u1ed5 phi\u1ebfu, xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn l\u1ec7nh, sau \u0111\u00f3 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a b\u1ea1n."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o Pyxis Oncology l\u00e0 g\u00ec?","answer":"R\u1ee7i ro bao g\u1ed3m ti\u1ec1n m\u1eb7t ch\u1ec9 \u0111\u1ee7 cho 21 th\u00e1ng ho\u1ea1t \u0111\u1ed9ng, kh\u1ea3 n\u0103ng th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng g\u00e2y gi\u1ea3m gi\u00e1 c\u1ed5 phi\u1ebfu tr\u00ean 50%, r\u1ee7i ro pha lo\u00e3ng do ph\u00e1t h\u00e0nh th\u00eam c\u1ed5 phi\u1ebfu, v\u00e0 bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng gi\u00e1 c\u1ee7a c\u1ed5 phi\u1ebfu PYXS trong t\u01b0\u01a1ng lai ra sao?","answer":"C\u00e1c nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 t\u0103ng l\u00ean 8,67 USD ho\u1eb7c h\u01a1n trong 2-5 n\u0103m t\u1edbi, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng ti\u1ec1m n\u0103ng t\u0103ng tr\u00ean 600% so v\u1edbi gi\u00e1 hi\u1ec7n t\u1ea1i."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n khi mua c\u1ed5 phi\u1ebfu PYXS?","answer":"L\u1ec7nh gi\u1edbi h\u1ea1n gi\u00fap b\u1ea1n ki\u1ec3m so\u00e1t gi\u00e1 mua, tr\u00e1nh mua \u1edf m\u1ee9c gi\u00e1 qu\u00e1 cao trong th\u1ecb tr\u01b0\u1eddng bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh nh\u01b0 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc."},{"question":"Pocket Option c\u00f3 nh\u1eefng l\u1ee3i th\u1ebf g\u00ec cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi quan t\u00e2m \u0111\u1ebfn Pyxis Oncology?","answer":"Pocket Option cho ph\u00e9p n\u1ea1p ti\u1ec1n t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD, x\u00e1c minh nhanh ch\u00f3ng, mua c\u1ed5 phi\u1ebfu l\u1ebb, v\u00e0 c\u00f3 h\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n linh ho\u1ea1t, r\u1ea5t ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi th\u1eed nghi\u1ec7m v\u1edbi s\u1ed1 v\u1ed1n nh\u1ecf."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u mua c\u1ed5 phi\u1ebfu Pyxis Oncology (PYXS)?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb, ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 PYXS, ch\u1ecdn lo\u1ea1i l\u1ec7nh gi\u1edbi h\u1ea1n, \u0111\u1eb7t s\u1ed1 l\u01b0\u1ee3ng c\u1ed5 phi\u1ebfu, xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn l\u1ec7nh, sau \u0111\u00f3 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a b\u1ea1n."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o Pyxis Oncology l\u00e0 g\u00ec?","answer":"R\u1ee7i ro bao g\u1ed3m ti\u1ec1n m\u1eb7t ch\u1ec9 \u0111\u1ee7 cho 21 th\u00e1ng ho\u1ea1t \u0111\u1ed9ng, kh\u1ea3 n\u0103ng th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng g\u00e2y gi\u1ea3m gi\u00e1 c\u1ed5 phi\u1ebfu tr\u00ean 50%, r\u1ee7i ro pha lo\u00e3ng do ph\u00e1t h\u00e0nh th\u00eam c\u1ed5 phi\u1ebfu, v\u00e0 bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng gi\u00e1 c\u1ee7a c\u1ed5 phi\u1ebfu PYXS trong t\u01b0\u01a1ng lai ra sao?","answer":"C\u00e1c nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 t\u0103ng l\u00ean 8,67 USD ho\u1eb7c h\u01a1n trong 2-5 n\u0103m t\u1edbi, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng ti\u1ec1m n\u0103ng t\u0103ng tr\u00ean 600% so v\u1edbi gi\u00e1 hi\u1ec7n t\u1ea1i."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n khi mua c\u1ed5 phi\u1ebfu PYXS?","answer":"L\u1ec7nh gi\u1edbi h\u1ea1n gi\u00fap b\u1ea1n ki\u1ec3m so\u00e1t gi\u00e1 mua, tr\u00e1nh mua \u1edf m\u1ee9c gi\u00e1 qu\u00e1 cao trong th\u1ecb tr\u01b0\u1eddng bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh nh\u01b0 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc."},{"question":"Pocket Option c\u00f3 nh\u1eefng l\u1ee3i th\u1ebf g\u00ec cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi quan t\u00e2m \u0111\u1ebfn Pyxis Oncology?","answer":"Pocket Option cho ph\u00e9p n\u1ea1p ti\u1ec1n t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD, x\u00e1c minh nhanh ch\u00f3ng, mua c\u1ed5 phi\u1ebfu l\u1ebb, v\u00e0 c\u00f3 h\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n linh ho\u1ea1t, r\u1ea5t ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi th\u1eed nghi\u1ec7m v\u1edbi s\u1ed1 v\u1ed1n nh\u1ecf."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-24T17:27:36+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS)\",\"datePublished\":\"2025-08-24T17:27:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"datePublished\":\"2025-08-24T17:27:36+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-24T17:27:36+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS)","datePublished":"2025-08-24T17:27:36+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","datePublished":"2025-08-24T17:27:36+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":345193,"slug":"how-to-buy-pyxis-oncology","post_title":"Como comprar a\u00e7\u00f5es da Pyxis Oncology, Inc. (PYXS) - Investimento em a\u00e7\u00f5es da Pyxis Oncology, Inc. (PYXS)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-pyxis-oncology\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/345190","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=345190"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/345190\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334099"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=345190"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=345190"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=345190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}